Insider Trading & Ownership - MPM Oncology Impact Management GP LLC

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for MPM Oncology Impact Management GP LLC
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-08-23
Sale
2021-08-25
7:42 pm
Cullinan Oncology Inc.CGEMUBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
10% Owner
105,894$29.29$3,101,3447,805,483
(Direct)
View
2021-08-11
Sale
2021-08-12
4:55 pm
Cullinan Oncology Inc.CGEMUBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
10% Owner
2,510$29.05$72,9167,911,377
(Direct)
View
2021-05-28
Sale
2021-06-02
6:09 pm
Harpoon Therapeutics Inc.HARPGADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
57,494$20.63$1,186,1906,328,095
(Indirect)
View
2021-05-26
Sale
2021-05-27
7:40 pm
Harpoon Therapeutics Inc.HARPGADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
17,159$20.22$346,9386,385,589
(Indirect)
View
2021-05-21
Sale
2021-05-24
8:11 pm
Harpoon Therapeutics Inc.HARPGADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
15,907$20.18$321,0306,402,748
(Indirect)
View
2021-05-18
Sale
2021-05-20
7:20 pm
Harpoon Therapeutics Inc.HARPGADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
47,948$20.49$982,2276,418,655
(Indirect)
View
2021-05-13
Sale
2021-05-17
5:23 pm
Harpoon Therapeutics Inc.HARPGADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
16,421$20.05$329,3146,466,603
(Indirect)
View
2021-05-10
Sale
2021-05-12
6:09 pm
Harpoon Therapeutics Inc.HARPGADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
68,262$21.04$1,436,5566,483,024
(Indirect)
View
2021-05-04
Purchase
2021-05-06
4:19 pm
Werewolf Therapeutics Inc.HOWLGADICKE ANSBERT
MPM ONCOLOGY INNOVATIONS FUND LP
UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Innovations Fund GP LLC
MPM Oncology Impact Management GP LLC
10% Owner
245,000$16$3,920,0006,672,183
(Indirect)
View
2021-05-05
Sale
2021-05-06
4:05 pm
Harpoon Therapeutics Inc.HARPGADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
10,172$22.52$229,1076,551,286
(Indirect)
View
2021-04-30
Sale
2021-05-04
5:43 pm
Harpoon Therapeutics Inc.HARPGADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
328,519$22.48$7,386,4356,561,458
(Indirect)
View
2021-04-27
Sale
2021-04-29
5:46 pm
Harpoon Therapeutics Inc.HARPGADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
130,143$21.99$2,861,3686,889,977
(Indirect)
View
2021-04-21
Sale
2021-04-22
4:04 pm
Harpoon Therapeutics Inc.HARPGADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
8,972$18.97$170,2297,020,120
(Indirect)
View
2021-04-16
Sale
2021-04-20
6:07 pm
Harpoon Therapeutics Inc.HARPGADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
38,152$19.04$726,5507,029,092
(Indirect)
View
2021-04-13
Sale
2021-04-15
8:00 pm
Harpoon Therapeutics Inc.HARPGADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
38,556$20.16$777,3597,067,244
(Indirect)
View
2021-04-09
Sale
2021-04-13
4:15 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
10% Owner
200$29.99$5,9986,004,368
(Indirect)
View
2021-04-09
Sale
2021-04-13
4:13 pm
Harpoon Therapeutics Inc.HARPGADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
30,928$21.9$677,3577,105,800
(Indirect)
View
2021-04-07
Sale
2021-04-09
4:47 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
10% Owner
41,982$30.99$1,300,8506,020,238
(Indirect)
View
2021-01-12
Purchase
2021-01-14
5:54 pm
Cullinan Management Inc.CGEMUBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
10% Owner
300,000$21$6,300,0007,913,887
(Direct)
View
2020-10-06
Purchase
2020-10-08
6:26 pm
Oncorus Inc.ONCRUBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
10% Owner
151,224$15$2,268,3602,377,025
(Direct)
View
2020-07-28
Purchase
2020-07-30
08:00 am
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
320,000$19$6,080,0002,355,557
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-05-04
Conversion
2021-05-06
4:19 pm
N/A
N/A
Werewolf Therapeutics Inc.HOWLGADICKE ANSBERT
MPM ONCOLOGY INNOVATIONS FUND LP
UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Innovations Fund GP LLC
MPM Oncology Impact Management GP LLC
10% Owner
57,683,698$06,672,183
(Indirect)
View

Ownership
2021-04-29
5:31 pm
N/A
N/A
Werewolf Therapeutics Inc.HOWLGADICKE ANSBERT
MPM ONCOLOGY INNOVATIONS FUND LP
UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Innovations Fund GP LLC
MPM Oncology Impact Management GP LLC
10% Owner
0$06,486,087
(Indirect)
View
2021-04-07
Other
2021-04-09
4:47 pm
N/A
N/A
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
10% Owner
15,670$06,020,238
(Indirect)
View
2021-01-12
Conversion
2021-01-14
5:54 pm
N/A
N/A
Cullinan Management Inc.CGEMUBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
10% Owner
7,613,887$07,913,887
(Direct)
View

Ownership(A)
2021-01-14
5:49 pm
N/A
N/A
Cullinan Management Inc.CGEMUBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
10% Owner
0$07,613,887
(Direct)
View
2020-10-06
Conversion
2020-10-08
6:26 pm
N/A
N/A
Oncorus Inc.ONCRUBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
10% Owner
2,225,801$02,377,025
(Direct)
View

Ownership
2020-10-01
7:23 pm
N/A
N/A
Oncorus Inc.ONCRUBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
10% Owner
0$02,252,947
(Direct)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
23,558,112$02,355,557
(Indirect)
View

Ownership
2020-07-23
7:22 pm
N/A
N/A
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
0$05,742,220
(Indirect)
View
(A) Indicate amendment filing.